Literature DB >> 2437944

Age-dependence and free fatty acid modulation of binding kinetics at the benzodiazepine binding site of serum albumin in neonates and adults determined using fast reaction methods.

G Menke, P Pfister, S Sauerwein, I Rietbrock, B G Woodcock, N Rietbrock.   

Abstract

Binding kinetics at the benzodiazepine binding site of albumin have been determined as a function of age and fatty acid concentration in serum from 32 neonates (umbilical cord blood), 28 adults aged 23-65 years and 24 adults aged 66-101 years using fluorescence-time curves obtained in a Durrum-Gibson stopped-flow apparatus and the specific marker ligand dansylsarcosine. The binding reaction can be described by a 2-step mechanism characterised by four constants: the association rate constant k2 and dissociation rate constant k-2 for the rate limiting step-2; the affinity constant KA' for the formation of an unstable intermediate complex in step-1; the affinity constant KA for the overall reaction. There were marked differences in k2 between the three groups of subjects with highest values occurring in neonates (mean: 296 s-1), intermediate values in adults aged 23-65 years (mean: 200 s-1, P less than 0.001) and lowest values in adults aged 66-101 years (mean: 144 s-1, P less than 0.001). The dissociation rate constants (k-2) averaged 18.5 s-1 overall, showed only minor changes with increasing age and corresponded to dissociation half-lives of 42 ms, 38 ms and 33 ms for neonates, adults 23-65 years and adults 66-101 years respectively. KA' in neonates and in the group of elderly subjects were lower than in adults aged 23-65 years.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437944      PMCID: PMC1386093          DOI: 10.1111/j.1365-2125.1987.tb03073.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  The characterization of two specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1975-11       Impact factor: 4.436

2.  Further characterization of specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

3.  Human serum albumin. Spectroscopic studies of binding and proximity relationships for fatty acids and bilirubin.

Authors:  C B Berde; B S Hudson; R D Simoni; L A Sklar
Journal:  J Biol Chem       Date:  1979-01-25       Impact factor: 5.157

4.  Kinetics of the binding of salicylazosulfapyridine to human serum albumin.

Authors:  J A Jansen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-11

5.  Characterization of the binding of benzodiazepines to human serum albumin.

Authors:  W Müller; U Wollert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  Influence of free fatty acid concentration on drug binding to plasma albumin.

Authors:  A A Spector; E C Santos; J D Ashbrook; J E Fletcher
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

7.  Levels of free fatty acids and arachidonic acid in pregnancy and labor.

Authors:  P L Ogburn; S B Johnson; P P Williams; R T Holman
Journal:  J Lab Clin Med       Date:  1980-06

8.  Plasma free fatty acid and blood sugar levels in newborn infants and their mothers.

Authors:  D K Keele; J L Kay
Journal:  Pediatrics       Date:  1966-04       Impact factor: 7.124

9.  Characteristic properties of fetal human albumin (Alb F) in isomerization equilibrium.

Authors:  K Miyoshi; K Saijo; Y Kotani; T Kashiwagi; H Kawai
Journal:  Tokushima J Exp Med       Date:  1966-11

10.  The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis.

Authors:  J Wilting; W F van der Giesen; L H Janssen; M M Weideman; M Otagiri; J H Perrin
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

View more
  5 in total

Review 1.  Protein binding: do we ever learn?

Authors:  Markus A Zeitlinger; Hartmut Derendorf; Johan W Mouton; Otto Cars; William A Craig; David Andes; Ursula Theuretzbacher
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

2.  The short-term effect of dietary pectin on plasma levels and renal excretion of dehydroepiandrosterone sulfate.

Authors:  T Remer; K Pietrzik; F Manz
Journal:  Z Ernahrungswiss       Date:  1996-03

Review 3.  Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.

Authors:  R Riva; F Albani; M Contin; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

4.  Kinetics of drug binding to human serum albumin: allosteric and competitive inhibition at the benzodiazepine binding site by free fatty acids of various chain lengths.

Authors:  G Menke; W Wörner; W Kratzer; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

5.  A physiologically based pharmacokinetic model for clobazam and stiripentol in adults and children.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  Pharm Res       Date:  2014-07-23       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.